Cairo – Mubasher: Minapharm Pharmaceuticals disclosed its consolidated income statements for fiscal year 2018, registered a decrease of 34.2% year-on-year in consolidated profits.
Consolidated income decreased to EGP 124.24 million in FY18 from EGP 189.07 million in FY17, according to a bourse filing on Wednesday.
During 2018, revenues grew to EGP 1.9 billion from EGP 1.6 billion in FY17.
